Biocept announces full commercial launch of cnside™ cerebrospinal fluid assay to address unmet needs for patients with metastatic brain cancer

San diego--(business wire)-- #cancer--biocept announces full launch of cnside, its csf assay designed to improve the management of metastatic cancers involving the central nervous system.

BIOC Ratings Summary

BIOC Quant Ranking